Over the past three years, Kalorama Information’s analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration:
Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery Volume III: Pulmonary Drug Delivery Volume IV: Transdermal and Transmucousal Drug Delivery Volume V: Advanced Drug Delivery
This series segmented the market by technology and included an innovative analysis that estimated the relative value of the technology component of marketed drug delivery products as opposed to the pharmaceutical component- an analysis used by many drug delivery companies to validate their positioning in partnerships and importance in the future market.
In 2003, with the publication of Advanced Drug Delivery: Technologies, Applications, and Markets, Kalorama looked at the market from the perspective of indication, quantifying the opportunity of modified delivery products in various therapeutic categories: cardiovascular disease, cancer, CNS, diabetes, women’s health, and pulmonary disease.
Along the way, Kalorama has also conducted studies on diabetes, women’s health, neurotherapeutics, and drug-eluting stents, some information from which has also been drawn on to compile this summary report.
This 50-page summary, compiled from Kalorama’s market research over the 2001-2003 period is designed to provide key information on drug delivery segment at a price significantly lower than any one full report. In addition to global market data for the various delivery routes, the summary also provides U.S. market potential estimates for seven key application sectors, listed in comparison to total sector estimates.